Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2,3 Dehydrosilybin
2. 2,3-dehydrosilybin
3. Alepa Forte
4. Alepa-forte
5. Ardeyhepan
6. Cefasilymarin
7. Durasilymarin
8. Hepa Loges
9. Hepa Merz Sil
10. Hepa-loges
11. Hepa-merz Sil
12. Hepabesch
13. Hepar Pasc
14. Hepar-pasc
15. Heparsyx
16. Heplant
17. Lagosa
18. Legalon Forte
19. Silibin
20. Silibinin
21. Silibinin A
22. Silibinin B
23. Silybin A
24. Silybin B
25. Silybinin
26. Carsil
27. Karsil
28. Legalon
29. Silimarin
30. Silymarin
1. Silybin A,b (mixture)
2. 802918-57-6
3. Silybin (a+b)
4. (2r,3r)-3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one
5. Legalon
6. Silibin
7. Silliver
8. Silybine
9. Silymarin
10. Chembl9509
11. Silibinin A-silibinin B Mixt.
12. Schembl14270800
13. Schembl22398934
14. Hy-n0779a
15. Cs-0138778
16. S0508
17. E80721
18. Silybin (mixture Of Silybin A And B) 100 Microg/ml In Acetonitrile
19. (2r,3r)-2,3-dihydro-3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-hydroxymethyl-2,3-dihydro-1,4-benzodioxin-6-yl]-4h-1-benzopyran-4-one
20. 2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-6-(3,5,7-trihydroxy-4-oxobenzopyran-2-yl)benzodioxine
Molecular Weight | 482.4 g/mol |
---|---|
Molecular Formula | C25H22O10 |
XLogP3 | 2.4 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 4 |
Exact Mass | 482.12129689 g/mol |
Monoisotopic Mass | 482.12129689 g/mol |
Topological Polar Surface Area | 155 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 750 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
Protective Agents
Synthetic or natural substances which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent. (See all compounds classified as Protective Agents.)
A - Alimentary tract and metabolism
A05 - Bile and liver therapy
A05B - Liver therapy, lipotropics
A05BA - Liver therapy
A05BA03 - Silymarin
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Reply
02 Jan 2025
Reply
10 Dec 2024
Reply
11 Nov 2024
Reply
19 Oct 2023
Reply
24 Apr 2023
Reply
05 Apr 2022
Reply
21 Jul 2020
Reply
20 Jul 2020
Reply
04 Dec 2018
Reply
13 Sep 2018
Reply
01 Aug 2023
Reply
15 Jul 2023
Reply
21 Jun 2023
Reply
09 Jun 2023
Reply
01 Jun 2023
Reply
15 Mar 2023
Reply
22 Nov 2022
Reply
04 Jul 2022
Reply
21 Jun 2022
Reply
23 Sep 2021
REF. STANDARDS & IMPURITIES
CAS Number : 72581-71-6
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : I0095.00
CAS Number : 36804-17-8
Quantity Per Vial : 20 MG
Sale Unit :
Price : Euro 240
Details : Purity > 98.0 %
Monograph :
Storage :
Code/Batch No : 7501094
CAS Number : 36804-17-8
Quantity Per Vial : 50 MG
Sale Unit :
Price : Euro 340
Details : Purity > 98.0 %
Monograph :
Storage :
Code/Batch No : 7501094
ABOUT THIS PAGE
A Silymarin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Silymarin, including repackagers and relabelers. The FDA regulates Silymarin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Silymarin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Silymarin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Silymarin supplier is an individual or a company that provides Silymarin active pharmaceutical ingredient (API) or Silymarin finished formulations upon request. The Silymarin suppliers may include Silymarin API manufacturers, exporters, distributors and traders.
click here to find a list of Silymarin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Silymarin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Silymarin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Silymarin GMP manufacturer or Silymarin GMP API supplier for your needs.
A Silymarin CoA (Certificate of Analysis) is a formal document that attests to Silymarin's compliance with Silymarin specifications and serves as a tool for batch-level quality control.
Silymarin CoA mostly includes findings from lab analyses of a specific batch. For each Silymarin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Silymarin may be tested according to a variety of international standards, such as European Pharmacopoeia (Silymarin EP), Silymarin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Silymarin USP).
LOOKING FOR A SUPPLIER?